top of page

Search

Choosing A Treatment Path for Your Patients in First AML Remission ~ Wednesday, November 8th!

Nov 6, 2023
0 min read

Recent Posts

A New Treatment Approach for Cisplatin-Ineligible Patients with MICB*

A New Treatment Approach for Cisplatin-Ineligible Patients with MICB*

New Event! Program on ZEPZELCA

New Event! Program on ZEPZELCA

New Event! RYBREVANT FASPRO + LAZCLUZE for EGDR + Locally Advanced or Metastatic NSLC

New Event! RYBREVANT FASPRO + LAZCLUZE for EGDR + Locally Advanced or Metastatic NSLC

Comments

bottom of page